Market Overview

Jefferies Downgrades Regeneron Pharmaceuticals, Inc. to Hold, Maintains $179.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for REGN

DateFirmActionFromTo
Aug 2016BairdDowngradesOutperformNeutral
Jun 2016BernsteinInitiates Coverage onOutperform
Apr 2016Wells FargoDowngradesOutperformMarket Perform

View More Analyst Ratings for REGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (REGN)